Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limited its clinical use. Our previous study found variability when laboratories used their own scoring methods on centrally stained tissue microarray slides. In this current study, 16 laboratories from eight countries calibrated to a specific Ki67 scoring method and then scored 50 centrally MIB-1 stained tissue microarray cases. Simple instructions prescribed scoring pattern and staining thresholds for determination of the percentage of stained tumor cells. To calibrate, laboratories scored 18 'training' and 'test' web-based images. Software tracked object selection and scoring. Success for the calibration was prespecified as Root Mean Square Er...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Background Postanalytic issues of Ki67 assessment in breast cancers like counting method standardisa...
<div><p>Background</p><p>Ki67 labeling index (LI) is used as a predictive marker and is associated w...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
BACKGROUND: In breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Pathological analysis of the nuclear proliferation biomarker Ki67 has multiple potential roles in br...
Aims: The nuclear proliferation marker Ki67 assayed by immunohistochemistry has multiple potential u...
International audienceAbstract Ki67 has potential clinical importance in breast cancer but has yet t...
Ki67 has potential clinical importance in breast cancer but has yet to see broad acceptance due to i...
Pathological analysis of the nuclear proliferation biomarker Ki67 has multiple potential roles in br...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Background Postanalytic issues of Ki67 assessment in breast cancers like counting method standardisa...
<div><p>Background</p><p>Ki67 labeling index (LI) is used as a predictive marker and is associated w...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limi...
BACKGROUND: In breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Pathological analysis of the nuclear proliferation biomarker Ki67 has multiple potential roles in br...
Aims: The nuclear proliferation marker Ki67 assayed by immunohistochemistry has multiple potential u...
International audienceAbstract Ki67 has potential clinical importance in breast cancer but has yet t...
Ki67 has potential clinical importance in breast cancer but has yet to see broad acceptance due to i...
Pathological analysis of the nuclear proliferation biomarker Ki67 has multiple potential roles in br...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Background Postanalytic issues of Ki67 assessment in breast cancers like counting method standardisa...
<div><p>Background</p><p>Ki67 labeling index (LI) is used as a predictive marker and is associated w...